129 related articles for article (PubMed ID: 32733709)
1. Changes in Amino Acid and Acylcarnitine Plasma Profiles for Distinguishing Patients with Multiple Sclerosis from Healthy Controls.
Kasakin MF; Rogachev AD; Predtechenskaya EV; Zaigraev VJ; Koval VV; Pokrovsky AG
Mult Scler Int; 2020; 2020():9010937. PubMed ID: 32733709
[TBL] [Abstract][Full Text] [Related]
2. Targeted metabolomics approach for identification of relapsing-remitting multiple sclerosis markers and evaluation of diagnostic models.
Kasakin MF; Rogachev AD; Predtechenskaya EV; Zaigraev VJ; Koval VV; Pokrovsky AG
Medchemcomm; 2019 Oct; 10(10):1803-1809. PubMed ID: 31803396
[TBL] [Abstract][Full Text] [Related]
3. Rapid determination of C4-acylcarnitine and C5-acylcarnitine isomers in plasma and dried blood spots by UPLC-MS/MS as a second tier test following flow-injection MS/MS acylcarnitine profile analysis.
Forni S; Fu X; Palmer SE; Sweetman L
Mol Genet Metab; 2010 Sep; 101(1):25-32. PubMed ID: 20591710
[TBL] [Abstract][Full Text] [Related]
4. Orange juice affects acylcarnitine metabolism in healthy volunteers as revealed by a mass-spectrometry based metabolomics approach.
Moreira V; Brasili E; Fiamoncini J; Marini F; Miccheli A; Daniel H; Lee JJH; Hassimotto NMA; Lajolo FM
Food Res Int; 2018 May; 107():346-352. PubMed ID: 29580494
[TBL] [Abstract][Full Text] [Related]
5. A rapid UPLC-MS/MS method for simultaneous separation of 48 acylcarnitines in dried blood spots and plasma useful as a second-tier test for expanded newborn screening.
Gucciardi A; Pirillo P; Di Gangi IM; Naturale M; Giordano G
Anal Bioanal Chem; 2012 Aug; 404(3):741-51. PubMed ID: 22766757
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis.
Poddighe S; Murgia F; Lorefice L; Liggi S; Cocco E; Marrosu MG; Atzori L
Int J Biochem Cell Biol; 2017 Dec; 93():148-155. PubMed ID: 28720279
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Acylcarnitine Species in db/db Mouse Using a Novel Method of High-Resolution Parallel Reaction Monitoring Reveals Widespread Metabolic Dysfunction Induced by Diabetes.
Xiang L; Wei J; Tian XY; Wang B; Chan W; Li S; Tang Z; Zhang H; Cheang WS; Zhao Q; Zhao H; Yang Z; Hong Y; Huang Y; Cai Z
Anal Chem; 2017 Oct; 89(19):10368-10375. PubMed ID: 28859482
[TBL] [Abstract][Full Text] [Related]
8. Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters.
Chace DH; Lim T; Hansen CR; De Jesus VR; Hannon WH
Clin Chim Acta; 2009 Sep; 407(1-2):6-9. PubMed ID: 19545553
[TBL] [Abstract][Full Text] [Related]
9. Amino acid and acylcarnitine profiles in perinatal asphyxia: a case-control study.
El-Farghali OG; El-Chimi MS; El-Abd HS; El-Desouky E
J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1462-1469. PubMed ID: 28412875
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
[TBL] [Abstract][Full Text] [Related]
11. Short-term stability of amino acids and acylcarnitines in the dried blood spots used to screen newborns for metabolic disorders.
Golbahar J; Altayab DD; Carreon E
J Med Screen; 2014 Mar; 21(1):5-9. PubMed ID: 24531510
[TBL] [Abstract][Full Text] [Related]
12. Differences between acylcarnitine profiles in plasma and bloodspots.
de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
[TBL] [Abstract][Full Text] [Related]
13. Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".
Minkler PE; Stoll MS; Ingalls ST; Kerner J; Hoppel CL
Mol Genet Metab; 2015 Dec; 116(4):231-41. PubMed ID: 26458767
[TBL] [Abstract][Full Text] [Related]
14. [Newborn screening program and blood amino acid profiling in early neonates with citrin deficiency].
Tang CF; Liu SC; Feng Y; Mei HF; Liu HP; Feng JW; Ye LX; Wang GQ; Liu L; Huang YL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):797-801. PubMed ID: 31594068
[No Abstract] [Full Text] [Related]
15. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders.
Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002
[TBL] [Abstract][Full Text] [Related]
16. Impaired acylcarnitine profile in transfusion-dependent beta-thalassemia major patients in Bangladesh.
Kumar Sarker S; Islam MT; Sarower Bhuyan G; Sultana N; Begum MN; Al Mahmud-Un-Nabi M; Al Noman Howladar MA; Farhana Dipta T; Muraduzzaman AKM; Kashfi Qadri S; Shirin T; Sadiya S; Hussain M; Ahmed Khan W; Akhteruzzaman S; Saleheen Qadri S; Qadri F; Mannoor K
J Adv Res; 2018 Jul; 12():55-66. PubMed ID: 30046479
[TBL] [Abstract][Full Text] [Related]
17. Altered Cerebrospinal Fluid Concentrations of Hydrophobic and Hydrophilic Compounds in Early Stages of Multiple Sclerosis-Metabolic Profile Analyses.
Podlecka-Piętowska A; Kacka A; Zakrzewska-Pniewska B; Nojszewska M; Zieminska E; Chalimoniuk M; Toczylowska B
J Mol Neurosci; 2019 Sep; 69(1):94-105. PubMed ID: 31134532
[TBL] [Abstract][Full Text] [Related]
18. Analysis and interpretation of acylcarnitine profiles in dried blood spot and plasma of preterm and full-term newborns.
Gucciardi A; Zaramella P; Costa I; Pirillo P; Nardo D; Naturale M; Chiandetti L; Giordano G
Pediatr Res; 2015 Jan; 77(1-1):36-47. PubMed ID: 25268144
[TBL] [Abstract][Full Text] [Related]
19. Alterations in plasma acylcarnitine and amino acid profiles may indicate poor nutrition during the suckling period due to maternal intake of an unbalanced diet and may predict later metabolic dysfunction.
Pomar CA; Kuda O; Kopecky J; Rombaldova M; Castro H; Picó C; Sánchez J; Palou A
FASEB J; 2019 Jan; 33(1):796-807. PubMed ID: 30080446
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
